Stimulant Dependence: Clinical Trials

7 trials for Stimulant Dependence, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 recruiting. 3 Not applicable, 3 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 2, Recruiting 1
Phase 23Completed 3
Phase 31Completed 1

Follow Stimulant Dependence: new trials by email Literature Review of Stimulant Dependence trials Research Report on Stimulant Dependence

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pilot TMS for Methamphetamine Use Disorder
Transcranial Magnetic Stimulation--DPFC first, MPFC second, Transcranial Magnetic Stimulation--MPFC first, DPFC second - Stimulant Dependence, Methamphetamine-dependence
Not applicableCompletedRyan M. Carnahan192020-10-062026-01-16
Substance Misuse To Psychosis for Stimulants
Aripiprazole, Paliperidone, Treatment as Usual - Stimulant Use With Stimulant-Induced Psychotic Disorder (Diagnosis), Schizophrenia and Related Disorders
Phase 2 / Phase 3CompletedThe University of Hong Kong1652019-06-012026-03-27
rTMS for Craving in Methamphetamine Use Disorder
Real Repetitive transcranial magnetic stimulation, Sham Repetitive transcranial magnetic stimulation, Methamphetamine visual cues - Methamphetamine Abuse, Substance Use Disorders
Not applicableRecruitingOregon Health and Science University502018-02-072026-09-23
Atomoxetine for ATS and Opioid Dependence During Buprenorphine Maintenance Treatment in Malaysia
Atomoxetine - Opiate Dependence, Stimulant Dependence
Phase 2CompletedYale University902013-05-012017-04-27
Mindfulness Based Relapse Prevention for Stimulant Users
Mindfulness Based Relapse Prevention, Health Education - Stimulant Dependence
Not applicableCompletedUniversity of California, Los Angeles622010-04-012022-04-29
An Eval of Neurocognitive Function, Oxidative Damage, and Their Association With Outcomes in METH and Cocaine Abusers.
Stimulant Dependence
CompletedUniversity of Cincinnati2172008-02-012015-12-30
CRAFT Behavior Therapy: Treatment Entry Component
Community Reinforcement and Family Training, Treatment Entry Training, 12- step Al/Nar- Anon Facilitation - Drug Addiction, Stimulant Dependence
Phase 2CompletedTreatment Research Institute1802006-01-012023-03-28

Narrower conditions

Substance-Related Disorders (3)  ·  Opioid-Related Disorders (2)  ·  Alcoholism (1)  ·  Behavior, Addictive (1)  ·  Disease (1)  ·  Psychotic Disorders (1)  ·  Schizophrenia (1)

Broader conditions

Mental Disorders (5)  ·  Chemically-Induced Disorders (4)  ·  Narcotic-Related Disorders (2)  ·  Alcohol-Related Disorders (1)  ·  Behavior (1)  ·  Compulsive Behavior (1)  ·  Impulsive Behavior (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (1)  ·  Substance-Related Disorders (1)

Interventions

Aripiprazole (1)  ·  Atomoxetine Hydrochloride (1)  ·  Paliperidone Palmitate (1)  ·  Therapeutics (1)

Sponsors

Oregon Health and Science University (1)  ·  Ryan M. Carnahan (1)  ·  The University of Hong Kong (1)  ·  Treatment Research Institute (1)  ·  University of California, Los Angeles (1)  ·  University of Cincinnati (1)  ·  Yale University (1)

Countries

United States (5)  ·  Hong Kong (1)  ·  Malaysia (1)

Top investigators

Alison C Lynch, MD, MS (1)  ·  Kimberly C Kirby, Ph.D. (1)  ·  Richard S Schottenfled, M.D. (1)  ·  Ryan Carnahan, PharmD, MS (1)  ·  Suzette Glasner, Ph.D. (1)  ·  Theresa Winhusen, Ph.D. (1)  ·  Vicknasingam B Kasinather, Ph.D. (1)

Results publications

PMID 22771145, PMID 23808868, PMID 42656845

NIH funding

R01DA018696 (1), U10DA013732 (1)